These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 196437

  • 1. [The effect of a combination treatment with clofibrate on the lipoprotein pattern of endogenous hypertriglyceridemia].
    Vogelberg KH, Althoff B, Heggen EM, Thesseling W.
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():832-5. PubMed ID: 196437
    [No Abstract] [Full Text] [Related]

  • 2. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
    Vogelberg KH.
    Dtsch Med Wochenschr; 1976 Dec 17; 101(51):1868-71. PubMed ID: 1001205
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].
    Koschinsky T, Lenhard P, Gries FA, Vogelberg KH, Wolfram G, Lang PD, Vollmar J.
    Med Klin; 1977 Sep 23; 72(38):1537-43. PubMed ID: 904549
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
    Gaertner U, Johannes KJ.
    MMW Munch Med Wochenschr; 1976 Sep 03; 118(36):1127-30. PubMed ID: 184377
    [Abstract] [Full Text] [Related]

  • 5. [Therapy of hyperlipemia and hyperuricemia with a combination of clofibrate and an extractive mucopolysaccharide complex].
    Loizzi P, Terlizzi N.
    Reumatismo; 1975 Sep 03; 27(1):157-62. PubMed ID: 184507
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
    Koschinsky T, Gries FA, Schwandt P, Weisweiler P, Hansen W, Nijssen J, Beckmann R.
    MMW Munch Med Wochenschr; 1977 May 20; 119(20):701-4. PubMed ID: 195201
    [Abstract] [Full Text] [Related]

  • 7. Familial lipoatrophic diabetes with dominant transmission. A new syndrome.
    Dunnigan MG, Cochrane MA, Kelly A, Scott JW.
    Q J Med; 1974 Jan 20; 43(169):33-48. PubMed ID: 4362786
    [No Abstract] [Full Text] [Related]

  • 8. [Comparative studies on the reduction of lipids using clofibric acid and clofibrate in hyperlipoproteinemias].
    Schwartzkopff W, Hoffmann H, Kästner W.
    Med Welt; 1975 Dec 19; 26(51):2308-15. PubMed ID: 177837
    [No Abstract] [Full Text] [Related]

  • 9. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R, Müller A, Klose G, Middelhoff G, Augustin J, Haase W, Greten H.
    MMW Munch Med Wochenschr; 1978 Apr 14; 120(15):525-8. PubMed ID: 206826
    [Abstract] [Full Text] [Related]

  • 10. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A.
    Postgrad Med J; 1975 Apr 14; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract] [Full Text] [Related]

  • 11. Gemfibrozil treatment: a comparison with clofibrate.
    Howard AN, Ghosh P.
    Proc R Soc Med; 1976 Apr 14; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
    [Abstract] [Full Text] [Related]

  • 12. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P, Schwandt P.
    Verh Dtsch Ges Inn Med; 1976 Apr 14; 83():398-401. PubMed ID: 206058
    [No Abstract] [Full Text] [Related]

  • 13. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia.
    Miettinen TA, Penttilä IM, Lampainen E.
    Acta Med Scand; 1972 Sep 14; 192(3):177-82. PubMed ID: 4341290
    [No Abstract] [Full Text] [Related]

  • 14. [Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV].
    Jantke J, Schwartzkopff W, Zschiedrich M.
    Verh Dtsch Ges Inn Med; 1972 Sep 14; 83():392-5. PubMed ID: 206057
    [No Abstract] [Full Text] [Related]

  • 15. Diet and drug treatment of hyperlipidemia and atherosclerosis.
    Kuo PT.
    Ann Clin Lab Sci (1971); 1972 Sep 14; 2(4):322-4. PubMed ID: 4342101
    [No Abstract] [Full Text] [Related]

  • 16. Secholex, Clofibrate and taurine in hyperlipidaemia.
    Howard AN, Evans RJ.
    Atherosclerosis; 1974 Sep 14; 20(1):105-16. PubMed ID: 4376405
    [No Abstract] [Full Text] [Related]

  • 17. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC.
    Pharmacotherapy; 1995 Sep 14; 15(3):317-37. PubMed ID: 7667166
    [Abstract] [Full Text] [Related]

  • 18. [The when and how of therapy for hyperlipoproteinemia].
    Mordasini R.
    Schweiz Med Wochenschr; 1978 Jan 28; 108(4):113-9. PubMed ID: 203028
    [Abstract] [Full Text] [Related]

  • 19. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S.
    G Clin Med; 1974 Jan 28; 55(1):27-39. PubMed ID: 4369524
    [No Abstract] [Full Text] [Related]

  • 20. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L, Olsson AG, Rössner S, Carlson LA.
    Postgrad Med J; 1975 Jan 28; 51(8):suppl 76-81. PubMed ID: 215986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.